Skip to main content
. Author manuscript; available in PMC: 2020 Oct 6.
Published in final edited form as: J Neurooncol. 2018 Nov 3;140(3):717–725. doi: 10.1007/s11060-018-03003-z

Figure 1.

Figure 1.

Kaplan Meier Analysis of OS and EFS

OS: 38% @ 1 year (95% CI: 14 – 63%), 7.7% @ 2 year (95% CI: 0.4 to 29.2%); median survival = 8.7 months (95% CI: 6.9, 20.9)

EFS: 31% @ 1 year (95% CI: 9 – 55%), 0% @ 2 years ; median survival = 6.6 months (95% CI: 2.7, 12.7)